Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohan K Manu

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Pharmacoeconomics - Open|August 2, 2019
Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in IndiaSuhaj Abdulsalim, Mazhuvancherry Kesavan Unnikrishnan, Mohan K Manu, et al.
Journal of the American College of Nutrition|September 2, 2020
Vitamin D in Prevention and Treatment of COVID-19: Current Perspective and Future ProspectsNavya Vyas, Shilia Jacob Kurian, Debasis Bagchi, et al.
Gut Pathogens|August 12, 2025
Gut microbiota profile in newly diagnosed pulmonary tuberculosis patients: an exploratory pilot study in southern IndiaTejaswini Baral, Shaik Mohammad Abdul Fayaz, Mohan K Manu, et al.
Journal of the American Nutrition Association|July 31, 2025
Effect of Probiotics Supplementation on Clinical, Humanistic, and Safety Outcomes in Patients With Tuberculosis: A Prospective Cohort Study in a Tertiary Healthcare Facility in South IndiaTejaswini Baral, Varun Kumar Sudha Gururaj, Mohan K Manu, et al.
Plos One|November 13, 2025
Exploring gut microbiota and its predicted functions in pulmonary tuberculosis: A multi-regional study using public 16S datasetsTejaswini Baral, Anwesh Maile, Nagarajaram Hampapathalu Adimurthy, et al.
Expert Opinion on Therapeutic Targets|March 31, 2025
Potential role of indole-3-propionic acid in tuberculosis: current perspectives and future prospectsTejaswini Baral, Aieshel Serafin Johnson, Mazhuvancherry Kesavan Unnikrishnan, et al.
Archives of Medical Research|March 31, 2021
Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future ProspectsShilia Jacob Kurian, Mazhuvancherry Kesavan Unnikrishnan, Sonal Sekhar Miraj, et al.
Expert Review of Anti-Infective Therapy|December 23, 2022
Impact of tuberculosis disease on human gut microbiota: a systematic reviewTejaswini Baral, Shilia Jacob Kurian, Levin Thomas, et al.
Annals of Medicine|November 9, 2024
Metformin use and its association with various outcomes in COVID-19 patients with diabetes mellitus: a retrospective cohort study in a tertiary care facilityMuhilvannan Somasundaram, Sanjay Kurian Mathew, Soumyajeet Paul, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Pharmacoeconomics - Open|August 2, 2019
Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in IndiaSuhaj Abdulsalim, Mazhuvancherry Kesavan Unnikrishnan, Mohan K Manu, et al.
Journal of the American College of Nutrition|September 2, 2020
Vitamin D in Prevention and Treatment of COVID-19: Current Perspective and Future ProspectsNavya Vyas, Shilia Jacob Kurian, Debasis Bagchi, et al.
Gut Pathogens|August 12, 2025
Gut microbiota profile in newly diagnosed pulmonary tuberculosis patients: an exploratory pilot study in southern IndiaTejaswini Baral, Shaik Mohammad Abdul Fayaz, Mohan K Manu, et al.
Journal of the American Nutrition Association|July 31, 2025
Effect of Probiotics Supplementation on Clinical, Humanistic, and Safety Outcomes in Patients With Tuberculosis: A Prospective Cohort Study in a Tertiary Healthcare Facility in South IndiaTejaswini Baral, Varun Kumar Sudha Gururaj, Mohan K Manu, et al.
Plos One|November 13, 2025
Exploring gut microbiota and its predicted functions in pulmonary tuberculosis: A multi-regional study using public 16S datasetsTejaswini Baral, Anwesh Maile, Nagarajaram Hampapathalu Adimurthy, et al.
Expert Opinion on Therapeutic Targets|March 31, 2025
Potential role of indole-3-propionic acid in tuberculosis: current perspectives and future prospectsTejaswini Baral, Aieshel Serafin Johnson, Mazhuvancherry Kesavan Unnikrishnan, et al.
Archives of Medical Research|March 31, 2021
Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future ProspectsShilia Jacob Kurian, Mazhuvancherry Kesavan Unnikrishnan, Sonal Sekhar Miraj, et al.
Expert Review of Anti-Infective Therapy|December 23, 2022
Impact of tuberculosis disease on human gut microbiota: a systematic reviewTejaswini Baral, Shilia Jacob Kurian, Levin Thomas, et al.
Annals of Medicine|November 9, 2024
Metformin use and its association with various outcomes in COVID-19 patients with diabetes mellitus: a retrospective cohort study in a tertiary care facilityMuhilvannan Somasundaram, Sanjay Kurian Mathew, Soumyajeet Paul, et al.
Pageof 4